Charles Schwab Investment Management Inc. Grows Stock Holdings in The Clorox Company (NYSE:CLX)

Charles Schwab Investment Management Inc. lifted its position in The Clorox Company (NYSE:CLX) by 1.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 723,906 shares of the company’s stock after buying an additional 13,038 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Clorox were worth $117,932,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of CLX. EntryPoint Capital LLC acquired a new stake in shares of Clorox during the first quarter worth about $39,000. SVB Wealth LLC boosted its position in Clorox by 82.8% in the 1st quarter. SVB Wealth LLC now owns 3,004 shares of the company’s stock valued at $460,000 after buying an additional 1,361 shares during the period. Janus Henderson Group PLC grew its stake in shares of Clorox by 7.2% in the first quarter. Janus Henderson Group PLC now owns 20,805 shares of the company’s stock worth $3,185,000 after acquiring an additional 1,400 shares in the last quarter. B. Riley Wealth Advisors Inc. increased its position in shares of Clorox by 11.4% during the first quarter. B. Riley Wealth Advisors Inc. now owns 6,762 shares of the company’s stock worth $1,035,000 after acquiring an additional 691 shares during the period. Finally, Meiji Yasuda Life Insurance Co acquired a new stake in shares of Clorox in the first quarter valued at $442,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently commented on CLX. Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research note on Friday, November 1st. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI lowered their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, DA Davidson raised their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a report on Monday, November 4th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $155.00.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.57% of the stock is owned by insiders.

Clorox Stock Performance

NYSE CLX opened at $166.32 on Tuesday. The company has a fifty day moving average of $162.79 and a two-hundred day moving average of $148.71. The company has a market capitalization of $20.59 billion, a PE ratio of 57.95, a P/E/G ratio of 3.13 and a beta of 0.41. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the business earned $0.49 EPS. As a group, analysts expect that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.93%. Clorox’s payout ratio is 170.04%.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.